Individual differences in pharmacokinetics and pharmacodynamics of anesthetic agent propofol with regard to CYP2B6 and UGT1A9 genotype and patient age
F Kansaku, T Kumai, K Sasaki, M Yokozuka… - Drug metabolism and …, 2011 - Elsevier
Propofol (2, 6-diisopropylphenol) is administered intravenously for induction and
maintenance of anesthesia; however, cases of progressive myocardial failure (propofol …
maintenance of anesthesia; however, cases of progressive myocardial failure (propofol …
Impact of clinical factors and UGT1A9 and CYP2B6 genotype on inter-individual differences in propofol pharmacokinetics
A Kanaya, T Sato, N Fuse, H Yamaguchi, N Mano… - Journal of …, 2018 - Springer
Purpose Propofol is one of the most widely used fast-acting intravenously administered
anesthetics. However, although large inter-individual differences in dose requirements and …
anesthetics. However, although large inter-individual differences in dose requirements and …
Influence of sex on propofol metabolism, a pilot study: implications for propofol anesthesia
I Loryan, M Lindqvist, I Johansson, M Hiratsuka… - European journal of …, 2012 - Springer
Purpose The basis of high intersubject variability of propofol metabolism is unclear.
Therefore, we examined the influence of genetic polymorphisms of the key metabolizing …
Therefore, we examined the influence of genetic polymorphisms of the key metabolizing …
[HTML][HTML] The effect of UGT1A9, CYP2B6 and CYP2C9 genes polymorphism on individual differences in propofol pharmacokinetics among Polish patients …
A Mikstacki, O Zakerska-Banaszak… - Journal of Applied …, 2017 - Springer
Abstract Propofol (2, 6-diisopropylphenol) is one of the safest and most commonly used
anaesthetic agents for intravenous general anaesthesia. However, in clinical practice, a …
anaesthetic agents for intravenous general anaesthesia. However, in clinical practice, a …
[HTML][HTML] Clinical importance of potential genetic determinants affecting propofol pharmacokinetics and pharmacodynamics
I Budic, T Jevtovic Stoimenov, D Pavlovic… - Frontiers in …, 2022 - frontiersin.org
Interindividual variability in response to drugs used in anesthesia has long been considered
the rule, not the exception. It is important to mention that in anesthesiology, the variability in …
the rule, not the exception. It is important to mention that in anesthesiology, the variability in …
Pharmacogenetics, plasma concentrations, clinical signs and EEG during propofol treatment
MS Khan, EL Zetterlund, H Gréen… - Basic & clinical …, 2014 - Wiley Online Library
A variety of techniques have been developed to monitor the depth of anaesthesia. Propofol's
pharmacokinetics and response vary greatly, which might be explained by genetic …
pharmacokinetics and response vary greatly, which might be explained by genetic …
Impact of the Cytochrome P450 2B6 (CYP2B6) Gene Polymorphism c.516G>T (rs3745274) on Propofol Dose Variability
AL Mourão, FG de Abreu, M Fiegenbaum - European journal of drug …, 2016 - Springer
Abstract Background and Objectives Propofol is the most commonly used hypnotic
worldwide, but its effective dose varies greatly between individuals. The present study …
worldwide, but its effective dose varies greatly between individuals. The present study …
The Effect of UGT1A9, CYP2B6 and CYP2C9 Genes Polymorphism on Propofol Pharmacokinetics in Children
D Pavlovic, I Budic, T Jevtovic Stoimenov… - Pharmacogenomics …, 2020 - Taylor & Francis
Purpose This study was conducted to determine the effect of UGT1A9 98T> C, CYP2B6
516G> T and CYP2C9 430C> T genetic polymorphisms on the pharmacokinetics of propofol …
516G> T and CYP2C9 430C> T genetic polymorphisms on the pharmacokinetics of propofol …
[HTML][HTML] CYP2B6 genotype guided dosing of propofol anesthesia in the elderly based on nonparametric population pharmacokinetic modeling and simulations
AR Eugene - International journal of clinical pharmacology & …, 2017 - ncbi.nlm.nih.gov
Objective The primary aim of this article is to test the hypothesis that nonparametric
pharmacometric modeling will accurately identify CYP2B6 genotype subgroups based on …
pharmacometric modeling will accurately identify CYP2B6 genotype subgroups based on …
An investigation of potential genetic determinants of propofol requirements and recovery from anaesthesia
G Iohom, MN Chonghaile, JK O'brien… - European journal of …, 2007 - cambridge.org
Background and objectiveThe objectives of this study were, firstly, to characterize the inter-
patient variability in the dose of propofol required to achieve a bispectral index< 70 and 'time …
patient variability in the dose of propofol required to achieve a bispectral index< 70 and 'time …
相关搜索
- propofol pharmacokinetics cyp2c9 genes
- propofol pharmacokinetics individual differences
- patient age individual differences
- propofol anesthesia cyp2b6 genotype
- propofol pharmacokinetics polish patients
- propofol pharmacokinetics clinical factors
- cyp2c9 genes individual differences
- polish patients individual differences
- propofol pharmacokinetics clinical importance